Ashwini Kumar
Overview
Explore the profile of Ashwini Kumar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
145
Citations
1174
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Verma G, Kumar V, Kumar A, Li W
Opt Lett
. 2025 Feb;
50(5):1560.
PMID: 40019981
We correct a typographical error in our Letter [Opt. Lett.49, 4074 (2024)10.1364/OL.527346]. The corrections have no influence on the results and conclusions of the original Letter.
2.
Gupta N, Kumar A, Santhosh S
Med J Armed Forces India
. 2025 Feb;
80(6):712-718.
PMID: 39990524
Background: Fatal aviation accidents are a critical concern for armed forces, necessitating precise toxicological analysis of postmortem blood samples. This paper introduces a novel spectrophotometric method for quantifying cyanide in...
3.
Basu B, Rahaman M, Ghosh S, Dutta S, Kumar A, Mukherjee S, et al.
Z Naturforsch C J Biosci
. 2025 Feb;
PMID: 39976502
Sericin, a protein extracted from the cocoons of silkworms, has recently become an attractive biomaterial due to its potential as a good candidate for wound healing especially wounds seen in...
4.
Nagime P, Pandey V, Rajpal C, Jayeoye T, Kumar A, Chidrawar V, et al.
Z Naturforsch C J Biosci
. 2025 Feb;
PMID: 39920565
Biogenic selenium nanoparticles (SeNPs) have emerged as promising area of research due to their unique properties and potential multifaceted applications. The biosynthesis of SeNPs through biological methods, such as using...
5.
Cohen Y, Magen H, Gatt M, Sebag M, Kim K, Min C, et al.
N Engl J Med
. 2025 Jan;
392(2):138-149.
PMID: 39778168
Background: Talquetamab (anti-G protein-coupled receptor family C group 5 member D) and teclistamab (anti-B-cell maturation antigen) are bispecific antibodies that activate T cells by targeting CD3 and that have been...
6.
Chaudhary A, Kumar A, Swain N, Chaudhary K, Sonker H, Dewan S, et al.
Small
. 2024 Nov;
:e2406809.
PMID: 39607393
Triple-negative breast cancer (TNBC) presents a formidable challenge due to its aggressive behavior and limited array of treatment options available. This study focuses on employing nanoaggregate material of organometallic Ir(III)...
7.
Mohite P, Puri A, Munde S, Ade N, Kumar A, Jantrawut P, et al.
Gels
. 2024 Nov;
10(11).
PMID: 39590075
Microneedle (MN) technology has emerged as a promising approach for delivering therapeutic agents to the skin, offering significant potential in treating various dermal conditions. Among these technologies, hydrogel-forming microneedles (HFMNs)...
8.
Prusty J, Kumar A, Kumar A
Crit Rev Microbiol
. 2024 Oct;
:1-37.
PMID: 39440616
infections, particularly invasive candidiasis, pose a serious global health threat. is the most prevalent species causing candidiasis, and resistance to key antifungal drugs, such as azoles, echinocandins, polyenes, and fluoropyrimidines,...
9.
Kumar A, Ranjan N, Mudgal S, Patidar V
Cureus
. 2024 Oct;
16(9):e69138.
PMID: 39398707
Background Varicose veins, affecting 8-10% of the population, are categorized as primary or secondary, depending on the etiology. The aim of the study is to assess the clinical profile of...
10.
Nagime P, Shaikh N, Shaikh S, Lokhande C, Patil V, Shafi S, et al.
Discov Nano
. 2024 Sep;
19(1):139.
PMID: 39227530
CPL-AgNPs exhibited improved biomimetic attributes. Antibiotic resistance against pathogens were challenged through use of CPL-AgNPs. Supercapacitor application of facile synthesized AgNPs for the first time demonstrated improved physical application.